NON-SMALL CELL LUNG
Clinical trials for NON-SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer drug combo shows promise in large trial
Disease control CompletedThis study tested whether adding the drug aflibercept to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. The trial included 913 patients whose cancer had worsened after initial platinum-based treatment. The main goal was t…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Lung cancer treatment breakthrough: drug combo before surgery shows promise
Disease control CompletedThis study tested whether adding the drug atezolizumab to standard chemotherapy before surgery helps people with early-stage lung cancer. About 450 adults with stage II or III non-small cell lung cancer took part. The goal was to see if the combination delays cancer return and im…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 04:33 UTC